Rare diseases
Investigational molecules
Locations
An Der Goldgrube 12, Oberstadt, 55131 Mainz, Germany
BioNTech SE focuses on advanced non-small cell lung cancer and small-cell lung cancer, including first-line, relapsed, and metastatic settings. Its trials also address broader advanced lung cancer populations and treatment-resistant disease.
Research in this area includes combination immunotherapy approaches and regimens paired with chemotherapy for patients with advanced thoracic malignancies.
BioNTech SE runs clinical trials in conditions such as Squamous cell carcinoma of lung, Non-small cell lung cancer, Non-small cell lung cancer stage III, Non-small cell lung cancer stage IV, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
FranceBelgiumFranceGermanyGermanyFrance
AustriaBelgium
SpainBelgium
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
